26 Feb, 2021 08:46 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, advises that SUDA has contracted the services of MedPharm, who will perform formulation development work to assist in stab...read more
16 Feb, 2021 08:19 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, announces that Zelira Therapeutics have elected not to proceed with further work and exercise their option to progress fro...read more
25 Jan, 2021 08:40 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated group for the second quarter of FY 2021.
Highlights
End of peri...read more
25 Jan, 2021 08:21 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, advises that Mitsubishi Tanabe Pharma Singapore Pte Ltd (MTPS) have indicated their intention not to proceed with the Lice...read more
22 Dec, 2020 09:05 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce the following letter to shareholders.
For the full document, please download the attached PDF.
16 Dec, 2020 10:24 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, announces that Laboratorios Ordesa S.L. have elected not to proceed with further work or exercise their option to progress...read more
16 Dec, 2020 10:24 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, is pleased to announce that they have received firm commitments for a capital raising by way of a placement of up to 76,708...read more
